1-5 of 5
Djibril Liassou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World (RW) Evaluation of Acute Myeloid Leukemia (AML) Induction Therapies in the Community Setting: A Retrospective Evaluation of Outcomes of Intensive Chemotherapy, Venetoclax-Based Regimens, and Non-IC-Based Treatments

Keri Maher, Cherrishe Brown-Bickerstaff, Ali McBride, Ajeet Gajra, Djibril Liassou, Ying Qiu, Marné Garretson, JaLyna Laney, David Huggar, David Hughes
Journal: Blood
Blood (2022) 140 (Supplement 1): 13278–13279.
https://doi.org/10.1182/blood-2022-169762
Published: 2022
Journal Articles

The Use of Fedratinib for Myelofibrosis As a Potential Bridge to Hematopoietic Stem Cell Transplantation after Ruxolitinib Failure: Real-World Assessment of Treatment Characteristics and Spleen, Symptom, and Hematologic Response

John Mascarenhas, Claire Harrison, Tammy Schuler, Djibril Liassou, Marné Garretson, Sankar Mahadevan, Ali McBride, Derek Tang, Irene S. DeGutis, Pranav Abraham, Aaron T. Gerds
Journal: Blood
Blood (2022) 140 (Supplement 1): 5276–5278.
https://doi.org/10.1182/blood-2022-156780
Published: 2022
Journal Articles

Real-World Treatment of Patients with Large B-Cell Lymphoma in the United States with Chimeric Antigen Receptor T-Cell Therapy

Kristin M. Zimmerman Savill, Andrew J Klink, Djibril Liassou, Dhruv Chopra, Jalyna Laney, Ajeet Gajra
Journal: Blood
Blood (2021) 138 (Supplement 1): 4096.
https://doi.org/10.1182/blood-2021-150723
Published: 2021
Journal Articles

Clinical Outcomes at 3 and 6 Months of Fedratinib Therapy Following Prior Ruxolitinib Failure: Real-World Assessment of Spleen, Symptoms, and Hematologic Response

John Mascarenhas, Aaron T. Gerds, Arianna Kee, Jonathan K. Kish, Pranav Abraham, Alexandrina Balanean, Jose Alberto Nadal, Djibril Liassou, Bruce A. Feinberg, Ali McBride, Claire N. Harrison
Journal: Blood
Blood (2021) 138 (Supplement 1): 1980.
https://doi.org/10.1182/blood-2021-145573
Published: 2021
Journal Articles

Real-World Utilization of Fedratinib for Myelofibrosis Post-Ruxolitinib: Patient Characteristics, Treatment Patterns, and Characterization of Ruxolitinib Failure

Claire N. Harrison, John Mascarenhas, Pranav Abraham, Arianna Kee, Jose Alberto Nadal, Alexandrina Balanean, Ali McBride, Jonathan K. Kish, Djibril Liassou, Bruce A. Feinberg, Aaron T. Gerds
Journal: Blood
Blood (2021) 138 (Supplement 1): 3059.
https://doi.org/10.1182/blood-2021-145569
Published: 2021